Acquisition of Stelco by US Steel Moves Ever Closer

United States Steel Corporation announced today that it has received approval of its acquisition of Stelco Inc. from the Canadian Minister of Industry under the Investment Canada Act.

In connection with the approval under the Investment Canada Act, U. S. Steel has made commitments to the Minister of Industry that highlight the net benefit to Canada that will arise from the acquisition. These include commitments relating to the funding of Stelco's main pension plans, increases in production and exports from Canada, significant capital expenditures at Stelco's facilities, R&D and the endowment of a Priority Chair in the Department of Materials Science and Engineering at McMaster University to facilitate the continuing development of steelmaking technology in Ontario, and the transfer of U. S. Steel's operating experience and best practices to the Stelco facilities.

Commenting on the approval, John P. Surma, U. S. Steel Chairman and CEO, said, "We are pleased with this news, which confirms that the Minister of Industry is satisfied that U. S. Steel's acquisition of Stelco will be of net benefit to Canada. U. S. Steel brings the financial strength, operating experience and advanced research and technology capability that are critical for the continued success of the Stelco facilities. We look forward to realizing the benefits of combining our operations with those of Stelco and to building on the unique talents, commitment and expertise of Stelco's employees."

All regulatory clearances required to complete the acquisition of Stelco have now been obtained.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.